mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.6 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.6 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.6 |